Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
Product: | Aciclovir-Baxter |
Active Ingredient: | Aciclovir 25mg/mL |
Dosage Form: | Solution for infusion |
New Zealand Sponsor: | Baxter Healthcare Limited |
Manufacturer: | Baxter Pharmaceuticals India Private Limited, Ahmedabad, India |
Product: | Trileptal |
Active Ingredient: | Oxcarbazepine 150mg |
Dosage Form: | Film coated tablet |
New Zealand Sponsor: | Novartis New Zealand Limited |
Manufacturers: | Novartis Pharma Stein AG, Stein, Switzerland Novartis Farma SpA, Torre Annunziata, Italy |
Product: | Trileptal |
Active Ingredient: | Oxcarbazepine 600mg |
Dosage Form: | Film coated tablet |
New Zealand Sponsor: | Novartis New Zealand Limited |
Manufacturers: | Novartis Pharma Stein AG, Stein, Switzerland Novartis Farma SpA, Torre Annunziata, Italy |
Dated this 19th day of April 2024.
DEREK FITZGERALD, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).